NOS2 and chronic obstructive pulmonary disease: In the context of models mimicking group 3 PH, the acute administration of the selective iNOS inhibitor MEG (mercaptoethylguanidine) alleviated lung edema, and decreased pulmonary and systemic vascular resistance with no effects on pulmonary and systemic arterial pressure, in an ovine model of COPD [157].